Takeda Pharmaceutical Co Ltd (NYSE:TAK)

20.50
Delayed Data
As of Nov 21
 -0.09 / -0.44%
Today’s Change
15.50
Today|||52-Week Range
21.61
+21.88%
Year-to-Date

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Takeda Pharmaceutical Co Ltd have a median target of 24.00, with a high estimate of 28.99 and a low estimate of 17.04. The median estimate represents a +17.09% increase from the last price of 20.50.

Analyst Recommendations

The current consensus among 13 polled investment analysts is to Buy stock in Takeda Pharmaceutical Co Ltd. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.14
Sales
$7.7B
Reporting Date
Jan 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -187.46%
 
 
 
 
 
 
Growthannually -237.02%
 
 
 
 
 
 

Sales

Growthquarterly 2.34%
 
 
 
 
 
 
Growthannually 60.77%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.